thallous chloride ti 201 Report issue

Small molecule Imaging Approved FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA MeSH PubChem

Active Ingredient History

NOW
  • Now
Thallous chloride (also known as Thallium(I) chloride) is a chemical compound with the formula TlCl. Thallous Chloride Tl 201 Injection is a diagnostic radiopharmaceutical indicated for: Myocardial perfusion imaging with planar scintigraphy or single-photon emission computed tomography (SPECT) for the diagnosis of coronary artery disease by localization of: Non-reversible defects (myocardial infarction) which may have prognostic value regarding survival. Reversible defects (myocardial ischemia) when used in conjunction with exercise or pharmacologic stress. Localization of sites of parathyroid hyperactivity pre- and post-operatively in patients with elevated serum calcium and parathyroid hormone levels.   NCATS

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Imaging: 201-thallium
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$5.6200 - $8.7100
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

201tl | thallium-201 chloride | thallium-201 monochloride | thallium (201tl) chloride | thallium chloride | thallium chloride (201tl) injection | thallium chloride, (201)tl-labeled | thallium chloride, (203)tl,(35)cl-labeled | thallium chloride, (203)tl,(37)cl-labeled | thallium chloride, (205)tl,(35)cl-labeled | thallium chloride, (205)tl,(37)cl-labeled | thallium(i) chloride | thallium monochloride | thallous chloride | thallous chloride ti 201 | thallous chloride tl 201 | thallous chloride tl-201

Organizations (6)

Research & Development (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (6)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (2)


 

Coronary Artery Disease (approved 1977)

Myocardial Infarction (approved 1977)

Experimental Indications - Clinical Trial Phases 1-4 (1)


 

Coronary Artery Disease (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial Organizations: 1

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue